Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ovarian Cancer
Researchers Report BRCA1 Gene Therapy Trial Results
November 24th, 1997
The first gene therapy trial using the BRCA1 "breast cancer gene" in patients with ovarian cancer demonstrated minimal side-effects and prompted little immune response, Vanderbilt Cancer Center (VCC), Nashville, Tennessee researchers and their colleagues reported. The promising results were presented in the November 1997 issue of the journal Clinical Cancer Research. Whether the body will thwart attempts at gene therapy by building immunity against the treatment is one of the concerns facing scientists working on this emerging field of medicine. "It's been very surprising to me that many of the women didn't produce...
Source: Cancer Weekly (1997-11-24)
|
